A new compound called 12g developed by researchers was found to protect mice from motor deficits associated with Parkinson’s disease.

The primary goal of treatment in PD is control of symptoms. Medications mostly work by increasing the levels of dopamine in the brain. Though the response is satisfactory in the initial periods, they effects may wear off with time. Stooped posture, movement issues such as frozen movements, and speech difficulties may fail to respond to drugs in the long run.
A team of researchers from South Korea tried to find out a way to shield the dopamine-releasing neurons from damage. Onyou Hwang, Ki Duk Park and colleagues developed 56 compounds and tested them. One of these compounds, named ‘12g’ was found to boost the production of proteins that protect neurons. It was found to protect mice from developing PD-like symptoms.
“Taken together, 12g was found to effectively prevent the motor deficits that are associated with PD,” said the team. The results came up in the American Chemical Society's Journal of Medicinal Chemistry.
Our current ammunition against PD include drugs and lifestyle changes. Levodopa, pramipexole, selegiline, are amantadine some the commonly prescribed drugs for PD. Surgical interventions such as deep brain stimulation have been attempted.
Reference: American Chemical Society
MEDINDIA




Email




